Literature DB >> 15060114

DBH gene variants that cause low plasma dopamine beta hydroxylase with or without a severe orthostatic syndrome.

J Deinum, G C H Steenbergen-Spanjers, M Jansen, F Boomsma, J W M Lenders, F J van Ittersum, N Hück, L P van den Heuvel, R A Wevers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15060114      PMCID： PMC1735728          DOI： 10.1136/jmg.2003.009282

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  18 in total

Review 1.  Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

Authors:  Colin N Haile; Thomas R Kosten; Therese A Kosten
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

Review 2.  A review of pharmacogenetic studies of substance-related disorders.

Authors:  Jermaine D Jones; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2015-03-18       Impact factor: 4.492

3.  Norepinephrine deficiency is caused by combined abnormal mRNA processing and defective protein trafficking of dopamine beta-hydroxylase.

Authors:  Chun-Hyung Kim; Amanda Leung; Yang Hoon Huh; Eungi Yang; Deog-Joong Kim; Pierre Leblanc; Hoon Ryu; Kyungjin Kim; Dong-Wook Kim; Emily M Garland; Satish R Raj; Italo Biaggioni; David Robertson; Kwang-Soo Kim
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

4.  Hyperinsulinemia and Insulin Resistance in Dopamine β-Hydroxylase Deficiency.

Authors:  Amy C Arnold; Emily M Garland; Jorge E Celedonio; Satish R Raj; Naji N Abumrad; Italo Biaggioni; David Robertson; James M Luther; Cyndya A Shibao
Journal:  J Clin Endocrinol Metab       Date:  2017-01-01       Impact factor: 5.958

5.  Neurocognitive function in dopamine-β-hydroxylase deficiency.

Authors:  Marieke Jepma; Jaap Deinum; Christopher L Asplund; Serge Arb Rombouts; Jouke T Tamsma; Nathanja Tjeerdema; Michiel M Spapé; Emily M Garland; David Robertson; Jacques Wm Lenders; Sander Nieuwenhuis
Journal:  Neuropsychopharmacology       Date:  2011-04-06       Impact factor: 7.853

6.  Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine β-hydroxylase.

Authors:  Thomas R Kosten; Guiying Wu; Wen Huang; Mark J Harding; Sara C Hamon; Jaakko Lappalainen; David A Nielsen
Journal:  Biol Psychiatry       Date:  2012-08-18       Impact factor: 13.382

7.  The C-1021T polymorphism of dopamine β-hydroxylase is not associated with orthostatic hypotension in a Chinese population.

Authors:  N Lu; J Chen; Y Yuan; X Cong; Y Yang; L Meng; K Sun; R Hui; Y Zheng
Journal:  J Hum Hypertens       Date:  2014-07-03       Impact factor: 3.012

8.  A patient with PMP22-related hereditary neuropathy and DBH-gene-related dysautonomia.

Authors:  Anna Bartoletti-Stella; Giacomo Chiaro; Giovanna Calandra-Buonaura; Manuela Contin; Cesa Scaglione; Giorgio Barletta; Annagrazia Cecere; Paolo Garagnani; Paolo Tieri; Alberto Ferrarini; Silvia Piras; Claudio Franceschi; Massimo Delledonne; Pietro Cortelli; Sabina Capellari
Journal:  J Neurol       Date:  2015-09-26       Impact factor: 4.849

9.  Mutations in CYB561 Causing a Novel Orthostatic Hypotension Syndrome.

Authors:  Maarten P van den Berg; Rowida Almomani; Italo Biaggioni; Martijn van Faassen; Pim van der Harst; Herman H W Silljé; Irene Mateo Leach; Marc H Hemmelder; Gerjan Navis; Gert Jan Luijckx; Arjan P M de Brouwer; Hanka Venselaar; Marcel M Verbeek; Paul A van der Zwaag; Jan D H Jongbloed; J Peter van Tintelen; Ron A Wevers; Ido P Kema
Journal:  Circ Res       Date:  2018-01-17       Impact factor: 17.367

Review 10.  Clinical presentation and long-term follow-up of dopamine beta hydroxylase deficiency.

Authors:  Tessa Wassenberg; Jaap Deinum; Frans J van Ittersum; Erik-Jan Kamsteeg; Maartje Pennings; Marcel M Verbeek; Ron A Wevers; Mirjam E van Albada; Ido P Kema; Jorie Versmissen; Ton van den Meiracker; Jacques W M Lenders; Leo Monnens; Michèl A Willemsen
Journal:  J Inherit Metab Dis       Date:  2020-10-15       Impact factor: 4.982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.